Somatuline Autogel · DIN 02283417 · 120 mg/Syr · extended release pre-filled syringe Pk
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Somatuline Autogel · DIN 02283417
Manufacturer: Ipsen Limited; listing date 2008-11-04
Health Canada: Marketed since 2021-12-15 · brand SOMATULINE AUTOGEL · ATC H01CB03 LANREOTIDE · form Solution (extended-release) · route Subcutaneous · ingredients LANREOTIDE (LANREOTIDE ACETATE) 120 MG/SYR · company Ipsen biopharmaceuticals canada inc · schedule Prescription
Ministry pays: $1268.9722 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02283417)
Source record
DIN 02283417: Somatuline Autogel
Raw flags: sec3=Y
Item: 920000584; group id 926; item number 2206; lccId None; manufacturer id IPS
Source form: ER Pref Syr Pk; strength: 120mg/Syr
Recorded listing: General benefit
Source prices (unrounded): $2422.5832; ministry $1268.9722
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02283417
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76902
Interchangeable products
Mytolac · DIN 02555883 · $1268.9722
Shortage status: not checked (no credentials)